Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)

NCT04236921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Other

Interventions

DRUG: DopaSnap®
DRUG: RDL of CD-LD

Sponsor

Riverside Pharmacueticals Corporation